KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Medpace Holdings (MEDP) Receivables - Other (2016 - 2026)

Medpace Holdings filings provide 12 years of Receivables - Other readings, the most recent being $24.2 million for Q1 2026.

  • On a quarterly basis, Receivables - Other rose 282.7% to $24.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $24.2 million, a 282.7% increase, with the full-year FY2025 number at $25.4 million, up 374.14% from a year prior.
  • Receivables - Other hit $24.2 million in Q1 2026 for Medpace Holdings, down from $25.4 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $43.8 million in Q2 2022 to a low of $5.3 million in Q4 2024.
  • Median Receivables - Other over the past 5 years was $24.2 million (2026), compared with a mean of $23.5 million.
  • Biggest five-year swings in Receivables - Other: crashed 81.09% in 2024 and later surged 374.14% in 2025.
  • Medpace Holdings' Receivables - Other stood at $40.4 million in 2022, then crashed by 44.38% to $22.5 million in 2023, then crashed by 76.21% to $5.3 million in 2024, then surged by 374.14% to $25.4 million in 2025, then dropped by 4.54% to $24.2 million in 2026.
  • The last three reported values for Receivables - Other were $24.2 million (Q1 2026), $25.4 million (Q4 2025), and $10.7 million (Q3 2025) per Business Quant data.